Neurogenesis, Inc.
OTC: NEUN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Keith J. Sullivan
- Employees
- 307
- Headquarters
- League City, United States
- IPO year
- 1998
- Market cap
- $8.2K
- Website
- https://www.neurogenesis.com
Loading NEUN…
Loading profile data…Frequently asked questions about NEUN
What does Neurogenesis, Inc. (NEUN) do?
Neurogenesis, Inc. manufactures and sells nutritional supplements primarily in the United States. The company offers NeuBecalm’d, a nutritional supplement to reduce the effects of acute and chronic stress factors; NeuBecalm'd Chewables that reduces the effects of stress and enhance focus; and NeuRecover, a nutritional support for the natural rep...
Where does NEUN trade?
Neurogenesis, Inc. (NEUN) trades on the Other OTC.
What sector is NEUN in?
Neurogenesis, Inc. (NEUN) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Neurogenesis, Inc.?
Keith J. Sullivan is the chief executive officer of Neurogenesis, Inc. (NEUN).
Where is Neurogenesis, Inc. headquartered?
Neurogenesis, Inc. is headquartered in United States.
Does NEUN pay a dividend?
Neurogenesis, Inc. (NEUN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NEUN go public?
Neurogenesis, Inc. (NEUN) completed its initial public offering in 1998.